29 April 2019
The use of oligonucleotides as therapeutics requires the packaging into nanoparticles. Positively charged peptides are one type of molecules to generate such nano-formulations. To this point, the inner architecture of these nanoparticles and how it depends on the relative amounts of oligonucleotide and peptide could not be resolved.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Prinses Beatrix Spierfonds grant to investigate patient stratification in myotonic dystrophy
24 January 2020 RIMLS researchers Rick Wansink and Roland Brock, both theme Nanomedicine, received a € 280,000 grant from the Prinses Beatrix Spierfonds. read more
RIMLS PhD grants awarded to eight RIMLS (j)PI's
12 September 2019 Recently, RIMLS held an internal call for Radboudumc junior researcher (PhD) positions. Congratulations for all the awardees and all the best in conducting the research projects. read more
TURBO grants for four medical-technical research projects
8 November 2018 Four TURBO grants were awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between Radboudumc and the University of Twente. read more